Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
DOI10.1002/BIMJ.201500234zbMATH Open1369.62306OpenAlexW2554645567WikidataQ39175273 ScholiaQ39175273MaRDI QIDQ5280185FDOQ5280185
Georg Heinze, Nils Ternès, Stefan Michiels, Federico Rotolo
Publication date: 20 July 2017
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.201500234
Recommendations
- Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials
- Identification of longitudinal biomarkers in survival analysis for competing risks data
- Adaptive clinical trial designs to detect interaction between treatment and a dichotomous biomarker
- Identifying optimal biomarker combinations for treatment selection via a robust kernel method
- The identification of potential longitudinal biomarkers and measurements of effectiveness for biomarkers as surrogates in multivariate survival data
- Buckley-James boosting for survival analysis with high-dimensional biomarker data
- Identification of potential longitudinal biomarkers under the accelerated failure time model in multivariate survival data
- Bayesian nonparametric estimation of targeted agent effects on biomarker change to predict clinical outcome
- Identification of longitudinal biomarkers for survival by a score test derived from a joint model of longitudinal and competing risks data
survivalvariable selectionmultiple testinghigh-dimensionalprecision medicinestratified medicinebiomarker-by-treatment interactions
Applications of statistics to biology and medical sciences; meta analysis (62P10) Paired and multiple comparisons; multiple testing (62J15) Testing in survival analysis and censored data (62N03)
Cites Work
- A lasso for hierarchical interactions
- Greedy function approximation: A gradient boosting machine.
- The Adaptive Lasso and Its Oracle Properties
- Title not available (Why is that?)
- Title not available (Why is that?)
- A Simple Method for Estimating Interactions Between a Treatment and a Large Number of Covariates
- Regularization and Variable Selection Via the Elastic Net
- Model Selection and Estimation in Regression with Grouped Variables
- Ridge Regression: Biased Estimation for Nonorthogonal Problems
- Title not available (Why is that?)
- A significance test for the lasso
- Boosting With theL2Loss
- Adaptive Lasso for Cox's proportional hazards model
- Operating Characteristics and Extensions of the False Discovery Rate Procedure
- Title not available (Why is that?)
Cited In (10)
- Oblique random survival forests
- IPF-LASSO: integrative \(L_1\)-penalized regression with penalty factors for prediction based on multi-omics data
- A three-stage approach to identify biomarker signatures for cancer genetic data with survival endpoints
- A Scalable Hierarchical Lasso for Gene–Environment Interactions
- Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials
- Two-step hypothesis testing to detect gene-environment interactions in a genome-wide scan with a survival endpoint
- Sparse classification with paired covariates
- Identifying optimal biomarker combinations for treatment selection via a robust kernel method
- Ranked sparsity: a cogent regularization framework for selecting and estimating feature interactions and polynomials
- Efficient screening of predictive biomarkers for individual treatment selection
Uses Software
This page was built for publication: Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5280185)
